Immunogen
$31.23
56
+$0.00+0% Friday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
28FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.31
-0.17
-0.02
0.12
Expected EPS
0.12
Actual EPS
N/A
Financials
-204.93%Profit Margin
Unprofitable108.78MRevenue
-222.93MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. Its product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha, which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and IMGN632, a CD123-targeting ADC that is in Phase I clinical trial for treating AML and blastic plasmacytoid dendritic cell neoplasm. Its preclinical program include IMGC936, an investigational ADC in co-development with MacroGenics, Inc. ImmunoGen, Inc. has collaborations with Roche; Amgen/Oxford BioTherapeutics; sanofi-aventis U. S. LLC; Biotest AG; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Takeda Pharmaceutical Company Limited; Fusion Pharmaceuticals Inc.; Debiopharm International SA; Jazz Pharmaceuticals Ireland Limited; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
Show more...
CEO
Mark Enyedy
Employees
79
Country
United States
ISIN
US45253H1014
WKN
000878613
Listings
0 Comments
Share your thoughts
FAQ
What is Immunogen stock price today?▼
The current price of IMGN is $31.23 USD — it has increased by +0% in the past 24 hours. Watch Immunogen stock price performance more closely on the chart.
What is Immunogen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Immunogen stocks are traded under the ticker IMGN.
What is Immunogen revenue for the last year?▼
Immunogen revenue for the last year amounts to 108.78M USD.
What is Immunogen net income for the last year?▼
IMGN net income for the last year is -222.93M USD.
How many employees does Immunogen have?▼
As of September 29, 2026, the company has 79 employees.
In which sector is Immunogen located?▼
Immunogen operates in the Manufacturing sector.
When did Immunogen complete a stock split?▼
Immunogen has not had any recent stock splits.
Where is Immunogen headquartered?▼
Immunogen is headquartered in Boston, United States.